Clinical trial
Study Using the MedPulser Electroporation System With Bleomycin to Treat…
NCT00198276 · Inovio Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00198276 |
|---|---|
| Title | Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer |
| Official title | An Open-Label Study Using the MedPulser Electroporation System to Treat Cutaneous and Subcutaneous Foci of Cancer |
| Lead sponsor | Inovio Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Combination Product |
| Interventions | MedPulser Electroporation with bleomycin |
| Enrollment | 88 |
| Start date | Feb 1, 2004 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: